News

Biogen, UCB Present Positive Phase 3 Results for Lupus Drug Candidate at EULAR 2025
Biogen Inc. (NASDAQ:BIIB) is one of the 11 most profitable NASDAQ stocks to buy now. On June 12, UCB and Biogen presented ...